Atlas Trials

Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Acute Non T Lymphocyte Leukemia

Clinical trial NCT02735291 · UNKNOWN

Trial details

NCT number
NCT02735291
Sponsor
Sinobioway Cell Therapy Co., Ltd.
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Leukemia
Start date
2015-11-01
Primary completion
2019-12-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.